CARBOXYALKYL CELLULOSE ESTERS FOR SUSTAINED DELIVERY OF PHARMACEUTICALLY ACTIVE SUBSTANCES
    1.
    发明申请
    CARBOXYALKYL CELLULOSE ESTERS FOR SUSTAINED DELIVERY OF PHARMACEUTICALLY ACTIVE SUBSTANCES 审中-公开
    用于持续输送药物活性物质的羧甲基纤维素酯

    公开(公告)号:WO2007056125A3

    公开(公告)日:2007-06-28

    申请号:PCT/US2006042931

    申请日:2006-11-03

    CPC classification number: A61K9/2054 A61K9/10 A61K9/2013 A61K9/4808 A61K31/717

    Abstract: Disclosed herein are pharmaceutical compositions comprising carboxyalkylcellulose esters for sustained delivery of pharmaceutically active substances. The composition comprises: at least one pharmaceutically active agent, and at least one carboxyalkyl cellulose ester comprising an anhydroglucose repeat unit having the structure (I), wherein: R 1 -R 6 are each independently selected from -OH, -OC(O)(alkyl), and -O(CH 2 ) X C(O)OH, and pharmaceutically acceptable salts thereof, wherein x ranges from 1-3, a degree of substitution per anhydroglucose of - OH ranges from 0.1 to 0.7, a degree of substitution per anhydroglucose of -C(O)(alkyl) ranges from 0.1 to 2.7, and a degree of substitution per anhydroglucose of -O(CH 2 ) X C(O)OH ranges from 0.2 to 0.75, and wherein in pharmaceutically acceptable media, the composition exhibits sustained release of the at least one pharmaceutically active agent. Also disclosed are methods of administering the compositions for sustained delivery, such as delivery following zero order kinetics.

    Abstract translation: 本文公开了包含用于持续递送药物活性物质的羧基烷基纤维素酯的药物组合物。 所述组合物包含:至少一种药学活性剂和至少一种含有具有结构(I)的脱水葡萄糖重复单元的羧基烷基纤维素酯,其中:R 1 -R 6 各自独立地选自-OH,-OC(O)(烷基)和-O(CH 2)2 C(O)OH,和其药学上可接受的盐 其中x为1-3,-OH的每个脱水葡萄糖的取代度为0.1-0.7,-C(O)(烷基)的每个脱水葡萄糖的取代度为0.1- 2.7, -O(CH 2)2 C(O)OH的每个脱水葡萄糖的取代范围为0.2至0.75,并且其中在药学上可接受的介质中,所述组合物显示持续释放 至少一种药物活性剂。 还公开了施用用于持续递送的组合物的方法,例如在零级动力学之后的递送。

Patent Agency Ranking